Globe Newswire

Shenzhen , June 14, 2024 (GLOBE NEWSWIRE) -- As an expert in the laser industry, Hymson has dedicated 16 years to laser application. It has accumulated profound expertise in product development and the integration of laser technology with automation, and has successfully deployed over a hundred types of high-end equipment in the LIB industry. Hymson was the first in China to develop a laser tab welding machine, and pioneered the application of laser notching machine... (continue reading...)

Toronto, ON, Canada, June 14, 2024 (GLOBE NEWSWIRE) -- SOPerior Fertilizer Corp. (the “Company” or “SOP”) (NEX:SOP.H). The Company is providing an update with respect to its Other Business Arrangement (“OBA”) renewal of the Blawn Mountain mineral leases which was previously disclosed in its press release of March 22, 2024. The Company in conjunction with its proposed JV counterparty is engaged in ongoing dialogue with Utah School and Institutional Trust Lands... (continue reading...)

• Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses
• Invivyd’s new data is broadly concordant with preliminary pseudovirus data showing neutralizing activity of VYD222 against KP.2 FLiRT and KP.3 variants recently publicized by an independent academic lab
• Invivyd’s... (continue reading...)

• Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses
• Invivyd’s new data is broadly concordant with preliminary pseudovirus data showing neutralizing activity of VYD222 against KP.2 FLiRT and KP.3 variants recently publicized by an independent academic lab
• Invivyd’s... (continue reading...)

LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD") for the Company's kidneyintelX.dkd testing. The final LCD can be accessed at LCD - KidneyIntelX and KidneyIntelX.dkd Testing (L39726) (cms.gov), and is effective for dates of service on or after August 1, 2024. The established Medicare price for kidneyintelX.dkd is $950 per test.... (continue reading...)